KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Nektar Therapeutics (NKTR) Debt Ratio (2016 - 2020)

Nektar Therapeutics has reported Debt Ratio over the past 10 years, most recently at 0.27 for Q1 2020.

  • Quarterly results put Debt Ratio at 0.27 for Q1 2020, up 136.08% from a year ago — trailing twelve months through Mar 2020 was 0.27 (up 136.08% YoY), and the annual figure for FY2019 was 0.13, up 11.36%.
  • Debt Ratio for Q1 2020 was 0.27 at Nektar Therapeutics, up from 0.13 in the prior quarter.
  • Over the last five years, Debt Ratio for NKTR hit a ceiling of 0.57 in Q3 2016 and a floor of 0.11 in Q2 2018.
  • Median Debt Ratio over the past 5 years was 0.42 (2017), compared with a mean of 0.32.
  • Biggest five-year swings in Debt Ratio: tumbled 79.28% in 2018 and later surged 136.08% in 2020.
  • Nektar Therapeutics' Debt Ratio stood at 0.43 in 2016, then rose by 12.59% to 0.48 in 2017, then plummeted by 76.17% to 0.11 in 2018, then rose by 11.36% to 0.13 in 2019, then soared by 110.78% to 0.27 in 2020.
  • The last three reported values for Debt Ratio were 0.27 (Q1 2020), 0.13 (Q4 2019), and 0.12 (Q3 2019) per Business Quant data.